(18)F-Fluorodeoxyglucose PET/MR Imaging in Lymphoma

Ivan Platzek1

  • 1Department of Radiology, Dresden University Hospital, Fetscherstr. 74, Dresden 01307, Germany.

PET Clinics
|September 6, 2016
PubMed

(18)F-Fluorodeoxyglucose (FDG) PET/MR imaging is feasible for initial staging and therapy response assessment in lymphoma. Although FDG PET/MR imaging is equivalent to FDG PET/CT for initial staging of lymphoma, not enough data are available with regard to other indications yet. Diffusion-weighted MR imaging is a promising addition to FDG PET/MR imaging, but has not been evaluated systematically.